The Bartonella quintana antibody (IgG) screen is a serological test designed to detect the presence of immunoglobulin G (IgG) antibodies specific to Bartonella quintana, a bacterium known for causing trench fever, bacillary angiomatosis, and endocarditis, particularly in immunocompromised individuals.
This test plays a critical role in the diagnostic process, especially in patients presenting with symptoms consistent with these conditions, such as prolonged fever, body aches, and in more severe cases, vascular lesions or heart valve infection.
The presence of B. quintana IgG antibodies indicates that the individual has been exposed to the bacterium, with their immune system generating a response.
Typically, these antibodies develop a few weeks following the initial exposure and can persist for an extended period, often years, suggesting either a past infection or a chronic, ongoing infection.
The B. quintana IgG screen is particularly valuable in epidemiological contexts where Bartonella infections are prevalent, such as among homeless populations or in areas with poor sanitation, where the bacterium is often transmitted through body lice.
A positive result in this test warrants careful interpretation; while it confirms exposure to B. quintana, it does not necessarily indicate an active infection, given the long-lasting nature of IgG antibodies. Therefore, clinicians must evaluate positive results in conjunction with the patient's clinical history, symptomatology, and potential risk factors, such as exposure to lice or poor living conditions, to make an accurate diagnosis.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.